POAI - Pendapatan operasional sadurunge ngurangi amortisasi predictive-oncology.com

Logo perusahaan publik Predictive Oncology Inc. (POAI)

The combination of a unique biobank and the CoMet AI platform creates a barrier to entry for competitors, while molecule discovery partnerships drive future growth for Predictive Oncology (POAI). On the EBITDA chart provided by the GURU.Markets platform, 0.00 represents the current metric. Ultimately, the company's strategy focuses on accelerating pharmaceutical trials and minimizing risks in the development of new drugs.

predictive-oncology.com (POAI) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi saka 23.11.2025 nganti 12.12.2025

Ringkesan rincian data analitis Predictive Oncology Inc. (POAI)

Pambiji fundamental perusahaan:POAI (Predictive Oncology)
Sampel barang Predictive Oncology Corp

This indicator measures real cash flow from core operations before taxes and interest payments, reflecting the internal efficiency of the business during periods of market volatility. An analysis of absolute EBITDA allows for an assessment of the resilience of Predictive Oncology (POAI), where steady growth of this metric confirms the demand for B2B subscriptions to its AI platform for oncology research among pharmaceutical behemoths.

Pesaing Predictive Oncology (POAI)

Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ISRG|Danaher Corp. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi bd.com BDX|STERIS (STE) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi WST|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Baxter Corp|Masimo Inc. (MASI) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi STVN (Stevanato Group S.p.A.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TFX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Merit Medical MMSI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NVST|ICUI: Bathi operasional sadurunge ngurangi amortisasi|XRAY - Bathi operasional EBITDA|LeMaitre Vascular, Inc. (LMAT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi atricure.com|STAA (STAAR Surgical) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi ChromaDex Corp NAGE|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ZimVie Dental (ZIMV)|AngioDynamics Inc. - Bathi operasional sadurunge amortisasi|Cerus Corporation - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TKNO (teknova.com)|MGRM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Sharps Technology, Inc. STSS|infusystem.com (INFU) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi UTMD (Utah Med)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi KORU Medical Systems, Inc.|NYXH: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA MBOT|PDEX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA ZTEK (Zentek Limited)|ELUT: Bathi operasional sadurunge amortisasi|Milestone Scientific - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi nexgel.com NXGL|RVP: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi harvardbioscience.com|Bathi operasional sadurunge ngurangi amortisasi FEMY|MHUA (Meihua Medical) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA CJMB|Pendapatan operasional sadurunge ngurangi amortisasi atrioncorp.com|NeuroMetrix - Bathi operasional sadurunge ngurangi amortisasi